To evaluate the safety of first-line systemic therapy for metastatic colorectal cancer through network meta-analysis.
No takes yet. Share an insight, caveat, or question.
Zhan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: